These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 6581755)

  • 21. N-Formimidoyl thienamycin (MK0787): in-vitro antibacterial activity and susceptibility to beta-lactamases compared with that of cefotaxime, moxalactam and other beta-lactam antibiotics.
    Hanslo D; King A; Shannon K; Warren C; Phillips I
    J Antimicrob Chemother; 1981 Jun; 7(6):607-17. PubMed ID: 6265426
    [No Abstract]   [Full Text] [Related]  

  • 22. Meropenem versus imipenem/cilastatin in the treatment of intra-abdominal infections.
    Brismar B; Malmborg AS; Tunevall G; Lindgren V; Bergman L; Mentzing LO; Nyström PO; Anséhn S; Bäckstrand B; Skau T
    J Antimicrob Chemother; 1995 Jan; 35(1):139-48. PubMed ID: 7768761
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Occurrence and expression of imipemide (N-formimidoyl thienamycin) resistance in clinical isolates of coagulase-negative staphylococci.
    Blumenthal RM; Raeder R; Takemoto CD; Freimer EH
    Antimicrob Agents Chemother; 1983 Jul; 24(1):61-9. PubMed ID: 6578701
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synergism of imipenem and amikacin in combination with other antibiotics against Nocardia asteroides.
    Gombert ME; Aulicino TM
    Antimicrob Agents Chemother; 1983 Nov; 24(5):810-1. PubMed ID: 6362558
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Susceptibility of gram-positive cocci to various antibiotics, including cefotaxime, moxalactam, and N-formimidoyl thienamycin.
    Cherubin CE; Corrado ML; Sierra MF; Gombert ME; Shulman M
    Antimicrob Agents Chemother; 1981 Oct; 20(4):553-5. PubMed ID: 6282200
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Imipenem (N-formimidoyl thienamycin): in vitro antimicrobial activity and beta-lactamase stability.
    Barry AL; Jones RN; Thornsberry C; Ayers LW; Kundargi R
    Diagn Microbiol Infect Dis; 1985 Mar; 3(2):93-104. PubMed ID: 3872196
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gram-positive superinfections following beta-lactam chemotherapy: the significance of the enterococcus.
    Jones RN
    Infection; 1985; 13 Suppl 1():S81-8. PubMed ID: 3902652
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vitro activity of N-formimidoyl thienamycin in comparison with cefotaxime, moxalactam, and ceftazidime.
    Verbist L; Verhaegen J
    Antimicrob Agents Chemother; 1981 Mar; 19(3):402-6. PubMed ID: 6264844
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparative in-vitro activity of MK0787 (N-formimidoyl thienamycin) against 540 blood culture isolates.
    Cohn DL; Reimer LG; Reller LB
    J Antimicrob Chemother; 1982 Mar; 9(3):183-94. PubMed ID: 6210653
    [No Abstract]   [Full Text] [Related]  

  • 30. Imipenem-cilastatin: the first thienamycin antibiotic.
    Jacobs RF
    Pediatr Infect Dis; 1986; 5(4):444-8. PubMed ID: 3523460
    [No Abstract]   [Full Text] [Related]  

  • 31. Timentin versus piperacillin or moxalactam in the therapy of acute bacterial infections.
    File TM; Tan JS; Salstrom SJ; Johnson LA; Douglas GF
    Antimicrob Agents Chemother; 1984 Sep; 26(3):310-3. PubMed ID: 6508263
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Moxalactam therapy of difficult infections in patients with serious underlying conditions.
    Mogabgab WJ; Bauman DC; LaCorte WF; Pollock B; Pauling B; Beville RB; Holmes BJ
    J Int Med Res; 1983; 11(5):269-78. PubMed ID: 6642067
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vitro susceptibility of Mycobacterium fortuitum to N-formimidoyl thienamycin and several cephamycins.
    Cynamon MH; Palmer GS
    Antimicrob Agents Chemother; 1982 Dec; 22(6):1079-81. PubMed ID: 6961887
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparative activity of N-formimidoyl thienamycin with third generation cephalosporins and ureido penicillins against multiple resistant Serratia marcescens.
    Miller MA; LeFrock JL; Vercler MJ
    Microbiol Immunol; 1981; 25(11):1119-27. PubMed ID: 6276701
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacokinetics and tolerance of N-formimidoyl thienamycin (MK0787) in humans.
    Norrby SR; Alestig K; Ferber F; Huber JL; Jones KH; Kahan FM; Meisinger MA; Rogers JD
    Antimicrob Agents Chemother; 1983 Feb; 23(2):293-9. PubMed ID: 6573156
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparative activities of N-formimidoyl thienamycin, ticarcillin, and tobramycin against experimental Pseudomonas aeruginosa pneumonia.
    Pennington JE; Johnson CE
    Antimicrob Agents Chemother; 1982 Sep; 22(3):406-8. PubMed ID: 6814354
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy of imipenem/cilastatin in patients with severe bacterial infections.
    Reutter FW
    J Antimicrob Chemother; 1986 Dec; 18 Suppl E():141-4. PubMed ID: 3469186
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Biapenem versus imipenem/cilastatin in the treatment of complicated intra-abdominal infections: report from a Swedish Study Group.
    Brismar B; Akerlund JE; Sjöstedt S; Johansson C; Törnqvist A; Bäckstrand B; Bång H; Andåker L; Gustafsson PO; Darle N; Angerås M; Falk A; Tunevall G; Kasholm-Tengve B; Skau T; Nyström PO; Gasslander T; Hagelbäck A; Olsson-Liljequist B; Eklund AE; Nord CE
    Scand J Infect Dis; 1996; 28(5):507-12. PubMed ID: 8953683
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Randomized prospective study comparing moxalactam and cefoxitin with or without tobramycin for the treatment of serious surgical infections.
    Tally FP; Kellum JM; Ho JL; O'Donnell TF; Barza M; Gorbach SL
    Antimicrob Agents Chemother; 1986 Feb; 29(2):244-9. PubMed ID: 3717931
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Meropenem versus imipenem/cilastatin in intra-abdominal infections requiring surgery. Meropenem Study Group.
    Geroulanos SJ
    J Antimicrob Chemother; 1995 Jul; 36 Suppl A():191-205. PubMed ID: 8543495
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.